BETHLEHEM, PA – October 17, 2019 — B. Braun Medical Inc. (B.Braun) announced today it has made significant investments to help ensure a stable drug supply to reduce the risk of tray backorders associated with market drug shortages.

“As the U.S leader in Regional Anesthesia,¹ patient care is our top priority. We are committed to providing you and your patients an uninterrupted supply of Regional Anesthesia procedural trays,” said Pete McGregor, Director of Marketing for Pain Control. “B. Braun continues to add products to our robust therapy portfolio that address post-operative pain and help reduce the use of opioids,” McGregor continued.  

Adequate pain management is crucial for medical and surgical procedures during the perioperative period. In order to manage pain - while reducing opioid consumption, including their associated side effects - multimodal pain management strategies have become an important part of the peri-operative care process. Replacing general anesthetic gas and opioid approaches in favor of combinations of regional and local methods, such as Neuraxial anesthesia (spinal / epidural approach) and regional nerve blocks (single shot or continuous infusion) are key.

As the U.S market leader in Regional Anesthesia,¹ B.Braun advocates and educates for the appropriate use of Regional Anesthesia and acute Pain Management to help manage the cost and complexity of healthcare delivery, while achieving improved patient and facility outcomes.

About B. Braun

B. Braun Medical Inc. (B.Braun) a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture, ostomy and wound care, and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap^® and CAPS^®.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise^® philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.

^{¹ 2018Q2 All Regional Anesthesia Products – Total Market HC & OPM Dollars (GHX, IQVIA [MDSA] & B. Braun Data On File)}